|
J. Biol. Chem., Vol. 265, Issue 17, 9788-9792, 06, 1990
Cloning and expression of human aldose reductase
C Nishimura, Y Matsuura, Y Kokai, T Akera, D Carper, N Morjana, C Lyons and TG Flynn
Department of Pediatric Pharmacology, National Children's Medical Research Center, Tokyo, Japan.
The complete amino acid sequence of human retina and muscle aldose
reductase was determined by nucleotide analysis of cDNA clones isolated
using synthetic oligonucleotide probes based on partial amino acid
sequences of purified human psoas muscle aldose reductase. The cDNA
sequence differs substantially in the noncoding and coding regions of
recently published sequences of this enzyme. The mRNA for aldose reductase
was abundantly expressed in HeLa cells, but only scarcely in a
neuroblastoma cell line. Recombinant baculovirus containing one of the
muscle cDNA clones was constructed and used to infect Spodoptera frugiperda
(SF9) cells. A prominent protein with an apparent molecular size of 36 kDa
was identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
in the culture medium as well as in the homogenate of SF9 cells after 2
days of infection. Culture medium or the supernatant fraction of cell
homogenates containing this protein had high aldose reductase activity
which showed characteristics of the reported human enzyme. These findings
indicate that the amino acid sequence reported in this paper represents
human retina and muscle aldose reductase and that functional human aldose
reductase can be expressed in large amounts in a baculovirus expression
system. The result should facilitate refined structural analysis and the
development of new specific aldose reductase inhibitors for the treatment
of diabetic complications.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. C. HWANG, M. KANEKO, S. BAKR, H. LIAO, Y. LU, E. R. LEWIS, S. YAN, S. II, M. ITAKURA, L. RUI, et al.
Central role for aldose reductase pathway in myocardial ischemic injury
FASEB J,
August 1, 2004;
18(11):
1192 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-L. HSIAO, F. DANGOND, T. YOSHIDA, R. HONG, R. V. JENSEN, J. MISRA, W. DILLON, K. F. LEE, K. E. CLARK, P. HAVERTY, et al.
A compendium of gene expression in normal human tissues
Physiol Genomics,
December 21, 2001;
7(2):
97 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yagihashi, S.-I. Yamagishi, R.-i. Wada, M. Baba, T. C. Hohman, C. Yabe-Nishimura, and Y. Kokai
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor
Brain,
December 1, 2001;
124(12):
2448 - 2458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yabe-Nishimura
Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications
Pharmacol. Rev.,
March 1, 1998;
50(1):
21 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E Heesom, A. Millward, and A. G Demaine
Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene
J. Neurol. Neurosurg. Psychiatry,
February 1, 1998;
64(2):
213 - 216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kubiseski and T. G. Flynn
Studies on Human Aldose Reductase
J. Biol. Chem.,
July 14, 1995;
270(28):
16911 - 16917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-L. HSIAO, F. DANGOND, T. YOSHIDA, R. HONG, R. V. JENSEN, J. MISRA, W. DILLON, K. F. LEE, K. E. CLARK, P. HAVERTY, et al.
A compendium of gene expression in normal human tissues
Physiol Genomics,
December 21, 2001;
7(2):
97 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|